EIR Ventures
Europe, Stockholms Lan, Sweden, Stockholm
Description
EIR Ventures is a new Life Science Venture Group in the Nordics.
Investor Profile
EIR Ventures has made 12 investments, with 2 in the past 12 months and 58% as lead.
Stage Focus
- Series A (42%)
- Series Unknown (25%)
- Seed (17%)
- Series D (8%)
- Series B (8%)
Country Focus
- Denmark (50%)
- Sweden (33%)
- United States (8%)
- The Netherlands (8%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Health Diagnostics
- Clinical Trials
- Biometrics
- Collaborative Consumption
- Life Science
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
